Intensive Exercise to Improve Mitochondrial Dysfunction in Pediatric Obesity

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT00962806
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH)
40
1
2
40
1

Study Details

Study Description

Brief Summary

Obesity and type 2 diabetes are occurring at epidemic rates in the United States and worldwide. The global burden of diabetes is estimated to double over the next 25 years. Obese children are at risk for the development of insulin resistance, relative insulin deficiency and type 2 diabetes mellitus (DM). The prevention of type 2 DM is hindered by the lack of a non-invasive predictive test, knowledge as to individual risk and effective preventative measures. There is increasing evidence that alterations in mitochondria contribute to the development of diabetes in humans. Therefore, it is important to explore mitochondrial dysfunction as a potential predictor of diabetes in children and a potential target for prevention. The aims of the proposed protocol are to determine whether an intensive exercise intervention can improve mitochondrial function in children identified as having mitochondrial dysfunction and insulin resistance. The use of a non-invasive imaging technique will allow for a functional in vivo assessment of mitochondrial activity. The investigators propose the investigation of an intensive exercise protocol designed to improve mitochondrial function in children who are insulin resistant and have documented mitochondrial dysfunction by magnetic resonance spectroscopy. The study is designed to investigate the plasticity of abnormal mitochondrial function in high risk children. In summary, the proposed projects will investigate mitochondrial function as a non-invasive predictive marker for the development of insulin resistance and type 2 diabetes mellitus in children and attempt to modify mitochondrial function with an intensive exercise intervention. The study of mitochondrial dysfunction in children may both identify those at risk for disease and provide a molecular therapeutic target for prevention and treatment.

The investigators hypothesize that children with insulin resistance and mitochondrial dysfunction who are randomized to intensive exercise versus standard lifestyle advice will show improvement in mitochondrial function and insulin sensitivity.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exercise
  • Behavioral: Lifestyle counseling
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Intensive Exercise to Improve Mitochondrial Dysfunction in Pediatric Obesity
Study Start Date :
Aug 1, 2009
Anticipated Primary Completion Date :
Jun 1, 2012
Anticipated Study Completion Date :
Dec 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Exercise

8 week intensive exercise group

Behavioral: Exercise
8 weeks of intensive exercise, 60-90 minutes 3 days each week

Other: Control Lifestyle counseling

Lifestyle counseling without intensive exercise

Behavioral: Lifestyle counseling
Baseline and final visit dietary and activity advice and weekly healthy lifestyle messages

Outcome Measures

Primary Outcome Measures

  1. Determine whether intensive exercise improves mitochondrial function by P31 MRS and mitochondrial number by peripheral blood analyses. [2 year]

Secondary Outcome Measures

  1. Determine whether intensive exercise improves metabolic parameters and glucose metabolism. [2 years]

  2. Determine whether intensive exercise improves body composition, by DXA, and intramyocellular fat content, by 1H MRS. [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Girls and boys ages 10 to 18 years old

  • Body mass index more than 95th percentile for age and gender

  • Insulin resistance based on:

  • Fasting parameters: Fasting insulin level, HOMA IR

  • Oral glucose tolerance testing

  • Mitochondrial function > 1 median for normal based on control cohort

Exclusion Criteria:
  • Underlying medical problem with potential to affect growth, pubertal development or glucose homeostasis

  • Chronic medical therapy with glucocorticoids, growth hormone, estrogen, progesterone, testosterone, or other medications with the potential to alter growth, pubertal development or glucose homeostasis within the proceeding 6 months

  • Personal history of DM

  • Inability to have MRI scan performed due to metal prosthesis or implant

Contacts and Locations

Locations

Site City State Country Postal Code
1 Massachusetts General Hospital Boston Massachusetts United States 02114

Sponsors and Collaborators

  • Massachusetts General Hospital
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amy Fleischman, MD, Assistant Professor, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00962806
Other Study ID Numbers:
  • DK084118
  • Partners IRB: 2009P-000173
First Posted:
Aug 20, 2009
Last Update Posted:
Apr 27, 2012
Last Verified:
Apr 1, 2012
Keywords provided by Amy Fleischman, MD, Assistant Professor, Massachusetts General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 27, 2012